Monoclonal Antibodies Market Report

Global Monoclonal Antibodies Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Aug 20, 2020
  • PAGES：146
  • REPORT CODE：GMM591090
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.

    The global monoclonal antibody market is valued at approximately US$145.7 billion in 2019 and is expected to grow to US$274 billion by 2026 at a CAGR of 9.44%. North America is the largest region in the monoclonal antibody market. Followed by Europe, Asia Pacific and the Middle East. The region is expected to remain the largest in the next six years. The Middle East monoclonal antibody market is expected to achieve the highest compound annual growth rate during 2020-2026.

    Increasing R&D activities in genomics and the emergence of technologically advanced genetic platforms such as next-generation sequencing are the main driving forces. In addition, the popularity of cost-effective biosimilar monoclonal antibodies is driving the growth of the monoclonal antibody market.

    The Monoclonal Antibodies is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period. The research provides insights for the global Monoclonal Antibodies market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Monoclonal Antibodies industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Monoclonal Antibodies Market Segmentations:

    By Players:

    • Roche

    • Johnson & Johnson

    • Seattle Genetics

    • MedImmune

    • Amgen

    • GlaxoSmithKline

    • Genmab

    • Human Genome Sciences

    • Takeda

    • Formation Biologics

    • mmunogen

    • Pfizer

    • Eli Lilly

    • Teva

    • Novartis

    • AbbVie

    • Synthon Biopharmaceuticals

    • Stemcentrx

    • BMS

    • Merck

    By Types:

    • Human Monoclonal Antibody

    • Humanized Monoclonal Antibody

    • Chimeric Monoclonal Antibody

    • Murine Monoclonal Antibody

    By End-User:

    • Oncology

    • Autoimmune and inflammatory diseases

    • Respiratory diseases

    • Ophthalmology

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Monoclonal Antibodies Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Monoclonal Antibodies Market Size and Growth Rate of Human Monoclonal Antibody from 2014 to 2026

      • 1.3.2 Global Monoclonal Antibodies Market Size and Growth Rate of Humanized Monoclonal Antibody from 2014 to 2026

      • 1.3.3 Global Monoclonal Antibodies Market Size and Growth Rate of Chimeric Monoclonal Antibody from 2014 to 2026

      • 1.3.4 Global Monoclonal Antibodies Market Size and Growth Rate of Murine Monoclonal Antibody from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Monoclonal Antibodies Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.2 Global Monoclonal Antibodies Market Size and Growth Rate of Autoimmune and inflammatory diseases from 2014 to 2026

      • 1.4.3 Global Monoclonal Antibodies Market Size and Growth Rate of Respiratory diseases from 2014 to 2026

      • 1.4.4 Global Monoclonal Antibodies Market Size and Growth Rate of Ophthalmology from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Monoclonal Antibodies Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Monoclonal Antibodies Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Monoclonal Antibodies by Major Types

      • 3.4.1 Monoclonal Antibodies Market Size and Growth Rate of Human Monoclonal Antibody

      • 3.4.2 Monoclonal Antibodies Market Size and Growth Rate of Humanized Monoclonal Antibody

      • 3.4.3 Monoclonal Antibodies Market Size and Growth Rate of Chimeric Monoclonal Antibody

      • 3.4.4 Monoclonal Antibodies Market Size and Growth Rate of Murine Monoclonal Antibody

    4 Segmentation of Monoclonal Antibodies Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Monoclonal Antibodies by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Monoclonal Antibodies in Oncology

      • 4.4.2 Market Size and Growth Rate of Monoclonal Antibodies in Autoimmune and inflammatory diseases

      • 4.4.3 Market Size and Growth Rate of Monoclonal Antibodies in Respiratory diseases

      • 4.4.4 Market Size and Growth Rate of Monoclonal Antibodies in Ophthalmology

    5 Market Analysis by Major Regions

    • 5.1 Global Monoclonal Antibodies Production Analysis by Major Regions

    • 5.2 Global Monoclonal Antibodies Consumption Analysis by Major Regions

    • 5.3 Global Monoclonal Antibodies Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Monoclonal Antibodies Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Monoclonal Antibodies Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Monoclonal Antibodies Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Monoclonal Antibodies Production, Import, Consumption and Export Analysis

    6 Product Commodity of Monoclonal Antibodies Market in Major Countries

    • 6.1 Top 5 Export Countries in Monoclonal Antibodies market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Monoclonal Antibodies market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Monoclonal Antibodies market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Monoclonal Antibodies market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Monoclonal Antibodies market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Monoclonal Antibodies market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Monoclonal Antibodies Landscape Analysis

    • 7.1 North America Monoclonal Antibodies Landscape Analysis by Major Types

    • 7.2 North America Monoclonal Antibodies Landscape Analysis by Major End-Users

    • 7.3 North America Monoclonal Antibodies Landscape Analysis by Major Countries

      • 7.3.1 United States Monoclonal Antibodies Market Volume and Growth Rate

      • 7.3.2 Canada Monoclonal Antibodies Market Volume and Growth Rate

      • 7.3.3 Mexico Monoclonal Antibodies Market Volume and Growth Rate

    8 Europe Monoclonal Antibodies Landscape Analysis

    • 8.1 Europe Monoclonal Antibodies Landscape Analysis by Major Types

    • 8.2 Europe Monoclonal Antibodies Landscape Analysis by Major End-Users

    • 8.3 Europe Monoclonal Antibodies Landscape Analysis by Major Countries

      • 8.3.1 Germany Monoclonal Antibodies Market Volume and Growth Rate

      • 8.3.2 UK Monoclonal Antibodies Market Volume and Growth Rate

      • 8.3.3 France Monoclonal Antibodies Market Volume and Growth Rate

      • 8.3.4 Italy Monoclonal Antibodies Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Monoclonal Antibodies Market Volume and Growth Rate

      • 8.3.6 Spain Monoclonal Antibodies Market Volume and Growth Rate

      • 8.3.7 Belgium Monoclonal Antibodies Market Volume and Growth Rate

      • 8.3.8 Poland Monoclonal Antibodies Market Volume and Growth Rate

      • 8.3.9 Russia Monoclonal Antibodies Market Volume and Growth Rate

      • 8.3.10 Turkey Monoclonal Antibodies Market Volume and Growth Rate

    9 Asia Pacific Monoclonal Antibodies Landscape Analysis

    • 9.1 Asia Pacific Monoclonal Antibodies Landscape Analysis by Major Types

    • 9.2 Asia Pacific Monoclonal Antibodies Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Monoclonal Antibodies Landscape Analysis by Major Countries

      • 9.3.1 China Monoclonal Antibodies Market Volume and Growth Rate

      • 9.3.2 Japan Monoclonal Antibodies Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Monoclonal Antibodies Market Volume and Growth Rate

      • 9.3.4 India Monoclonal Antibodies Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Monoclonal Antibodies Market Volume and Growth Rate

      • 9.3.6 South Korea Monoclonal Antibodies Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Monoclonal Antibodies Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Monoclonal Antibodies Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Monoclonal Antibodies Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Monoclonal Antibodies Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Monoclonal Antibodies Market Volume and Growth Rate

      • 10.3.2 Brazil Monoclonal Antibodies Market Volume and Growth Rate

      • 10.3.3 Nigeria Monoclonal Antibodies Market Volume and Growth Rate

      • 10.3.4 South Africa Monoclonal Antibodies Market Volume and Growth Rate 

      • 10.3.5 Argentina Monoclonal Antibodies Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Roche

      • 11.1.1 Roche Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Johnson & Johnson

      • 11.2.1 Johnson & Johnson Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Seattle Genetics

      • 11.3.1 Seattle Genetics Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 MedImmune

      • 11.4.1 MedImmune Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Amgen

      • 11.5.1 Amgen Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 GlaxoSmithKline

      • 11.6.1 GlaxoSmithKline Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Genmab

      • 11.7.1 Genmab Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Human Genome Sciences

      • 11.8.1 Human Genome Sciences Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Takeda

      • 11.9.1 Takeda Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Formation Biologics

      • 11.10.1 Formation Biologics Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 mmunogen

      • 11.11.1 mmunogen Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Pfizer

      • 11.12.1 Pfizer Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Eli Lilly

      • 11.13.1 Eli Lilly Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Teva

      • 11.14.1 Teva Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Novartis

      • 11.15.1 Novartis Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 AbbVie

      • 11.16.1 AbbVie Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Synthon Biopharmaceuticals

      • 11.17.1 Synthon Biopharmaceuticals Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Stemcentrx

      • 11.18.1 Stemcentrx Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 BMS

      • 11.19.1 BMS Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Merck

      • 11.20.1 Merck Company Profile and Recent Development

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 99 Figures and 132 Tables)

    • Figure Product Picture

    • Figure Monoclonal Antibodies Market Size and Growth Rate of Human Monoclonal Antibody from 2014 to 2026

    • Figure Monoclonal Antibodies Market Size and Growth Rate of Humanized Monoclonal Antibody from 2014 to 2026

    • Figure Monoclonal Antibodies Market Size and Growth Rate of Chimeric Monoclonal Antibody from 2014 to 2026

    • Figure Monoclonal Antibodies Market Size and Growth Rate of Murine Monoclonal Antibody from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Monoclonal Antibodies Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Global Monoclonal Antibodies Market Size and Growth Rate of Autoimmune and inflammatory diseases from 2014 to 2026

    • Figure Global Monoclonal Antibodies Market Size and Growth Rate of Respiratory diseases from 2014 to 2026

    • Figure Global Monoclonal Antibodies Market Size and Growth Rate of Ophthalmology from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Monoclonal Antibodies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Monoclonal Antibodies Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Monoclonal Antibodies

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Monoclonal Antibodies by Different Types from 2014 to 2026

    • Table Consumption Share of Monoclonal Antibodies by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Human Monoclonal Antibody

    • Figure Market Size and Growth Rate of Humanized Monoclonal Antibody

    • Figure Market Size and Growth Rate of Chimeric Monoclonal Antibody

    • Figure Market Size and Growth Rate of Murine Monoclonal Antibody

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Monoclonal Antibodies by Different End-Users from 2014 to 2026

    • Table Consumption Share of Monoclonal Antibodies by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Autoimmune and inflammatory diseases

    • Figure Market Size and Growth Rate of Respiratory diseases

    • Figure Market Size and Growth Rate of Ophthalmology

    • Table Global Monoclonal Antibodies Production by Major Regions

    • Table Global Monoclonal Antibodies Production Share by Major Regions

    • Figure Global Monoclonal Antibodies Production Share by Major Regions in 2014

    • Figure Global Monoclonal Antibodies Production Share by Major Regions in 2018

    • Figure Global Monoclonal Antibodies Production Share by Major Regions in 2026

    • Table Global Monoclonal Antibodies Consumption by Major Regions

    • Table Global Monoclonal Antibodies Consumption Share by Major Regions

    • Figure Global Monoclonal Antibodies Consumption Share by Major Regions in 2014

    • Figure Global Monoclonal Antibodies Consumption Share by Major Regions in 2018

    • Figure Global Monoclonal Antibodies Consumption Share by Major Regions in 2026

    • Table North America Monoclonal Antibodies Production, Import, Consumption and Export Analysis

    • Table Europe Monoclonal Antibodies Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Monoclonal Antibodies Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Monoclonal Antibodies Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Monoclonal Antibodies market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Monoclonal Antibodies market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Monoclonal Antibodies market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Monoclonal Antibodies market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Monoclonal Antibodies Consumption by Types from 2014 to 2026

    • Table North America Monoclonal Antibodies Consumption Share by Types from 2014 to 2026

    • Figure North America Monoclonal Antibodies Consumption Share by Types in 2014

    • Figure North America Monoclonal Antibodies Consumption Share by Types in 2018

    • Figure North America Monoclonal Antibodies Consumption Share by Types in 2026

    • Table North America Monoclonal Antibodies Consumption by End-Users from 2014 to 2026

    • Table North America Monoclonal Antibodies Consumption Share by End-Users from 2014 to 2026

    • Figure North America Monoclonal Antibodies Consumption Share by End-Users in 2014

    • Figure North America Monoclonal Antibodies Consumption Share by End-Users in 2018

    • Figure North America Monoclonal Antibodies Consumption Share by End-Users in 2026

    • Table North America Monoclonal Antibodies Consumption by Major Countries from 2014 to 2026

    • Table North America Monoclonal Antibodies Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Monoclonal Antibodies Consumption Share by Major Countries in 2014

    • Figure North America Monoclonal Antibodies Consumption Share by Major Countries in 2018

    • Figure North America Monoclonal Antibodies Consumption Share by Major Countries in 2026

    • Figure United States Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Monoclonal Antibodies Consumption by Types from 2014 to 2026

    • Table Europe Monoclonal Antibodies Consumption Share by Types from 2014 to 2026

    • Figure Europe Monoclonal Antibodies Consumption Share by Types in 2014

    • Figure Europe Monoclonal Antibodies Consumption Share by Types in 2018

    • Figure Europe Monoclonal Antibodies Consumption Share by Types in 2026

    • Table Europe Monoclonal Antibodies Consumption by End-Users from 2014 to 2026

    • Table Europe Monoclonal Antibodies Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Monoclonal Antibodies Consumption Share by End-Users in 2014

    • Figure Europe Monoclonal Antibodies Consumption Share by End-Users in 2018

    • Figure Europe Monoclonal Antibodies Consumption Share by End-Users in 2026

    • Table Europe Monoclonal Antibodies Consumption by Major Countries from 2014 to 2026

    • Table Europe Monoclonal Antibodies Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Monoclonal Antibodies Consumption Share by Major Countries in 2014

    • Figure Europe Monoclonal Antibodies Consumption Share by Major Countries in 2018

    • Figure Europe Monoclonal Antibodies Consumption Share by Major Countries in 2026

    • Figure Germany Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure France Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Monoclonal Antibodies Consumption by Types from 2014 to 2026

    • Table Asia Pacific Monoclonal Antibodies Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Monoclonal Antibodies Consumption Share by Types in 2014

    • Figure Asia Pacific Monoclonal Antibodies Consumption Share by Types in 2018

    • Figure Asia Pacific Monoclonal Antibodies Consumption Share by Types in 2026

    • Table Asia Pacific Monoclonal Antibodies Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Monoclonal Antibodies Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Monoclonal Antibodies Consumption Share by End-Users in 2014

    • Figure Asia Pacific Monoclonal Antibodies Consumption Share by End-Users in 2018

    • Figure Asia Pacific Monoclonal Antibodies Consumption Share by End-Users in 2026

    • Table Asia Pacific Monoclonal Antibodies Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Monoclonal Antibodies Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Monoclonal Antibodies Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Monoclonal Antibodies Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Monoclonal Antibodies Consumption Share by Major Countries in 2026

    • Figure China Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandMonoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure India Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Monoclonal Antibodies Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Monoclonal Antibodies Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Monoclonal Antibodies Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Monoclonal Antibodies Consumption Share by Major Countries in 2026

    • Figure GCC Countries Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Monoclonal Antibodies Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Seattle Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seattle Genetics

    • Figure Sales and Growth Rate Analysis of Seattle Genetics

    • Figure Revenue and Market Share Analysis of Seattle Genetics

    • Table Product and Service Introduction of Seattle Genetics

    • Table Company Profile and Development Status of MedImmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune

    • Figure Sales and Growth Rate Analysis of MedImmune

    • Figure Revenue and Market Share Analysis of MedImmune

    • Table Product and Service Introduction of MedImmune

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Genmab

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genmab

    • Figure Sales and Growth Rate Analysis of Genmab

    • Figure Revenue and Market Share Analysis of Genmab

    • Table Product and Service Introduction of Genmab

    • Table Company Profile and Development Status of Human Genome Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Human Genome Sciences

    • Figure Sales and Growth Rate Analysis of Human Genome Sciences

    • Figure Revenue and Market Share Analysis of Human Genome Sciences

    • Table Product and Service Introduction of Human Genome Sciences

    • Table Company Profile and Development Status of Takeda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

    • Figure Sales and Growth Rate Analysis of Takeda

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Product and Service Introduction of Takeda

    • Table Company Profile and Development Status of Formation Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Formation Biologics

    • Figure Sales and Growth Rate Analysis of Formation Biologics

    • Figure Revenue and Market Share Analysis of Formation Biologics

    • Table Product and Service Introduction of Formation Biologics

    • Table Company Profile and Development Status of mmunogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of mmunogen

    • Figure Sales and Growth Rate Analysis of mmunogen

    • Figure Revenue and Market Share Analysis of mmunogen

    • Table Product and Service Introduction of mmunogen

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Synthon Biopharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthon Biopharmaceuticals

    • Figure Sales and Growth Rate Analysis of Synthon Biopharmaceuticals

    • Figure Revenue and Market Share Analysis of Synthon Biopharmaceuticals

    • Table Product and Service Introduction of Synthon Biopharmaceuticals

    • Table Company Profile and Development Status of Stemcentrx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stemcentrx

    • Figure Sales and Growth Rate Analysis of Stemcentrx

    • Figure Revenue and Market Share Analysis of Stemcentrx

    • Table Product and Service Introduction of Stemcentrx

    • Table Company Profile and Development Status of BMS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BMS

    • Figure Sales and Growth Rate Analysis of BMS

    • Figure Revenue and Market Share Analysis of BMS

    • Table Product and Service Introduction of BMS

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US